Literature DB >> 26421121

A Rare Case of Adrenal Pheochromocytoma with Unusual Clinical and Biochemical Presentation: 
A Case Report and Literature Review.

Waad-Allah S Mula-Abed1, Riyaz Ahmed2, Fatima A Ramadhan3, Manal K Al-Kindi1, Noor B Al-Busaidi4, Hilal N Al-Muslahi4, Mohammad A Al-Lamki5.   

Abstract

A 50-year-old Omani woman presented to the Outpatient Clinic, Royal Hospital, Oman with right upper abdominal pain and backache that had lasted 10 days. She had no palpitation, sweating, or hypertension (blood pressure 122/78mmHg). The patient's history revealed that she had a similar incidence of abdominal pain two months prior, which was a "dull ache" in nature and somewhat associated with headache. The pain was relieved using a mild analgesic drug. Abdominal ultrasonography showed a right adrenal mass, and both computed tomography and magnetic resonance imaging of the adrenal glands confirmed a right adrenal mass consistent with adrenal pheochromocytoma. However, clinical biochemistry tests revealed normal levels of plasma catecholamines (dopamine, norepinephrine, and epinephrine) and metanephrine, which are unusual findings in adrenal pheochromocytoma. Meanwhile, the patient had markedly raised plasma normetanephrine (10-fold) which, together with the normal metanephrine, constitutes a metabolic profile that is compatible with extra-adrenal pheochromocytoma. The patient also had markedly raised chromogranin A (16-fold), consistent with the presence of a neuroendocrine tumor. Laparoscopic right adrenalectomy was done and the adrenal tumor was excised and retrieved in total. Histopathology and immunohistochemistry confirmed the diagnosis of adrenal pheochromocytoma; the tumor cells being positive for chromogranin, synaptophysin, and S-100 protein. Following surgery, the patient did well and showed full recovery at follow-up after three months. Molecular genetic testing showed no pathogenic mutation in pheochromocytoma genes: MAX, SDHA, SDHAF2, SDHB, SDHC, SDHD, VHL, and PRKAR1A. A review of the literature was conducted to identify the pathophysiology and any previous reports of such case. To our knowledge, this is the first report in Oman of the extremely rare entity of pheochromocytoma with an unusual clinical and biochemical scenario.

Entities:  

Keywords:  Adrenal glands; Adrenalectomy; Catecholamines; Chromogranin A; Metanephrine; Normetanephrine; Pheochromocytoma

Year:  2015        PMID: 26421121      PMCID: PMC4576385          DOI: 10.5001/omj.2015.76

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  29 in total

1.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

2.  Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids.

Authors:  R J Wurtman; J Axelrod
Journal:  J Biol Chem       Date:  1966-05-25       Impact factor: 5.157

Review 3.  Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease.

Authors:  Irvin M Modlin; Bjorn I Gustafsson; Steven F Moss; Marianne Pavel; Apostolos V Tsolakis; Mark Kidd
Journal:  Ann Surg Oncol       Date:  2010-03-09       Impact factor: 5.344

4.  The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency.

Authors:  N Zuckerman-Levin; D Tiosano; G Eisenhofer; S Bornstein; Z Hochberg
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

5.  Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.

Authors:  G Eisenhofer; M M Walther; T T Huynh; S T Li; S R Bornstein; A Vortmeyer; M Mannelli; D S Goldstein; W M Linehan; J W Lenders; K Pacak
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

6.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

Authors:  Karel Pacak; Graeme Eisenhofer; Håkan Ahlman; Stefan R Bornstein; Anne-Paule Gimenez-Roqueplo; Ashley B Grossman; Noriko Kimura; Massimo Mannelli; Anne Marie McNicol; Arthur S Tischler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

7.  Prevalence Pattern of Risk Factors for Coronary Artery Disease among Patients Presenting for Coronary Artery Bypass Grafting in Oman.

Authors:  Rajeeva Rivikath Pieris; Hilal Ali Al-Sabti; Qasim Saleh Abdullah Al-Abri; Syed Gauhar Alam Rizvi
Journal:  Oman Med J       Date:  2014-05

Review 8.  New imaging approaches to phaeochromocytomas and paragangliomas.

Authors:  Bas Havekes; Kathryn King; Edwin W Lai; Johannes A Romijn; Eleonora P M Corssmit; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-08       Impact factor: 3.478

Review 9.  Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma.

Authors:  Huma Q Rana; Irene R Rainville; Anand Vaidya
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-06       Impact factor: 3.243

10.  The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.

Authors:  Y Ito; Y Fujimoto; T Obara
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.